125 related articles for article (PubMed ID: 21454208)
21. Angiogenesis in Waldenström's macroglobulinemia.
Terpos E; Tasidou A; Kastritis E; Eleftherakis-Papaiakovou E; Gavriatopoulou M; Migkou M; Dimopoulos MA
Clin Lymphoma Myeloma; 2009 Mar; 9(1):46-9. PubMed ID: 19362971
[TBL] [Abstract][Full Text] [Related]
22. Macroglobulinemia and chronic B-cell type lymphocytic leukemia in japan--study of autopsy cases.
Kikuchi M; Mitsui T; Takeshita M; Okamura H
Jpn J Clin Oncol; 1983 Sep; 13(3):607-22. PubMed ID: 6417377
[TBL] [Abstract][Full Text] [Related]
23. Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.
Arcaini L; Varettoni M; Boveri E; Orlandi E; Rattotti S; Zibellini S; Merli M; Lucioni M; Rizzi S; Gotti M; Morello L; Pascutto C; Paulli M
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):103-5. PubMed ID: 21454204
[TBL] [Abstract][Full Text] [Related]
24. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
25. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic spectrum of Waldenström's macroglobulinemia: a single center experience.
Sajid R; Siddiqui SH; Shaikh U; Adil S
Indian J Pathol Microbiol; 2010; 53(3):490-3. PubMed ID: 20699509
[TBL] [Abstract][Full Text] [Related]
27. The bone marrow niche in Waldenström's macroglobulinemia.
Ghobrial IM; Zhang Y; Liu Y; Ngo H; Azab F; Sacco A; Azab A; Maiso P; Morgan B; Quang P; Issa G; Roccaro A
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):118-20. PubMed ID: 21454209
[TBL] [Abstract][Full Text] [Related]
28. Bone-marrow plasma cell burden correlates with IgM paraprotein concentration in Waldenstrom macroglobulinaemia.
Pasricha SR; Juneja SK; Westerman DA; Came NA
J Clin Pathol; 2011 Jun; 64(6):520-3. PubMed ID: 21471142
[TBL] [Abstract][Full Text] [Related]
29. Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.
Roberts MJ; Chadburn A; Ma S; Hyjek E; Peterson LC
Am J Clin Pathol; 2013 Feb; 139(2):210-9. PubMed ID: 23355206
[TBL] [Abstract][Full Text] [Related]
30. Assessment of bone marrow response in Waldenström's macroglobulinemia.
Varghese AM; Rawstron AC; Ashcroft AJ; Moreton P; Owen RG
Clin Lymphoma Myeloma; 2009 Mar; 9(1):53-5. PubMed ID: 19362973
[TBL] [Abstract][Full Text] [Related]
31. Associated malignancies in patients with Waldenström's macroglobulinemia and their kin.
Hanzis C; Ojha RP; Hunter Z; Manning R; Lewicki M; Brodsky P; Ioakimidis L; Tripsas C; Patterson CJ; Sheehy P; Treon SP
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):88-92. PubMed ID: 21454200
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous Waldenstrom's macroglobulinemia with "deck-chair" sign treated with cyclophosphamide.
Autier J; Buffet M; Pinquier L; Merlat-Guitard AI; Carlotti A; Franck N; Gorin I; Dupin N
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):45-7. PubMed ID: 15692513
[TBL] [Abstract][Full Text] [Related]
33. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.
Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E
Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024
[TBL] [Abstract][Full Text] [Related]
34. [Hypercalcemia complicating Waldenström's disease: a manifestation of Richter's syndrome].
Casassus P; Vannetzel JM; Tricot G; D'Agay MF; Lortholary P; Desrues J; Pariente P
Ann Med Interne (Paris); 1983; 134(2):130-3. PubMed ID: 6410954
[TBL] [Abstract][Full Text] [Related]
35. Updates in prognostication and treatment of Waldenström's macroglobulinemia.
Advani P; Paulus A; Ailawadhi S
Hematol Oncol Stem Cell Ther; 2019 Dec; 12(4):179-188. PubMed ID: 31158330
[TBL] [Abstract][Full Text] [Related]
36. The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.
Al-Katib AM; Mensah-Osman E; Aboukameel A; Mohammad R
Semin Oncol; 2003 Apr; 30(2):313-7. PubMed ID: 12720160
[TBL] [Abstract][Full Text] [Related]
37. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V
Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907
[TBL] [Abstract][Full Text] [Related]
38. Key role of microRNAs in Waldenström's macroglobulinemia pathogenesis.
Sacco A; Maiso P; Azab A; Azab F; Zhang Y; Liu Y; Ngo HT; Morgan B; Quang P; Issa G; Ghobrial IM; Roccaro AM
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):109-11. PubMed ID: 21454206
[TBL] [Abstract][Full Text] [Related]
39. Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.
Greco A; Tedeschi A; Varettoni M; Nichelatti M; Paris L; Ricci F; Vismara E; Morra E
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):77-9. PubMed ID: 21454196
[TBL] [Abstract][Full Text] [Related]
40. Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling.
Tournilhac O; Santos DD; Xu L; Kutok J; Tai YT; Le Gouill S; Catley L; Hunter Z; Branagan AR; Boyce JA; Munshi N; Anderson KC; Treon SP
Ann Oncol; 2006 Aug; 17(8):1275-82. PubMed ID: 16788002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]